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Photodynamic therapy of malignant and premalignant lesions
in patients with 'field cancerization' of the oral cavity
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Abstract
The management of patients with 'field cancerization' of the oral mucosa, with multicentric foci of invasion,
presents a considerable problem for the head and neck surgeon. Surgical resection of synchronous or
metachronous primary squamous cell carcinomas, along with adjacent premalignant lesions, is likely to be
associated with considerable mutilation. Photodynamic therapy (PDT) has been shown to be of value in the
treatment of superficial tumours in the upper aerodigestive tract, with excellent healing of treated areas. This
study reports the use of PDT to treat 11 patients with 'field cancerization' occurring in the oral cavity. Six
patients had multiple primary cancers and five had single primary tumours. All had associated areas of
leukoplakia. Each received Photofrin 2 mg/kg 48 hours prior to photoirradiation with 50-100 J/cm2 red laser
light by surface illumination. Six to eight weeks later treated areas in 10 of the 11 patients showed a complete
response to PDT; one patient had areas of residual leukoplakia. Two patients developed further areas of
leukoplakia or erythroplakia within 12 months but no patient has had evidence of recurrent invasive carcinoma
in the treated areas. Longer term follow-up will be necessary to exclude further recurrence. It is concluded that
PDT offers an effective repeatable treatment option, whether on its own or as an adjunct to local excision, for
patients with 'field cancerization' of the oral cavity.
Key words: Photodynamic therapy; Head and neck neoplasms
Introduction
The coexistence of premalignant lesions such as leuko-
plakia and erythroplakia with an existing primary lesion
greatly increases the chance of developing a second
primary cancer (Sarasin, 1933; Wilkins and Vogler, 1957;
Moertal and Foss, 1958; Shibuya et al., 1986). Leuko-
plakia, a term describing a white patch or plaque that can-
not be characterized clinically or pathologically as any
other disease entity (Kramer et al., 1978), has a definite
propensity for malignant transformation. This is variously
estimated as being between 0.13 and 17.5 per cent (Pind-
borg et al., 1968; Silverman etal., 1976; Silverman etai,
1984). The presence of an erythematous component,
erythroplakia, or erythroleukoplakia increases almost
fourfold the risk of malignant transformation (Silverman
etal., 1984). The incidence of multiple oral carcinomas in
patients with primary tongue carcinomas associated with
leukoplakia has been found to be five times greater than
that of subjects without leukoplakia (Shibuya et al.,
1986). The prognosis of patients who develop synchro-
nous or metachronous second primary cancers is poor
with overall five-year survival ranging from nine to 22 per
cent (Marchetta et al., 1965; Gluckman and Crissman,
1983). Slaughter et al. (1953) first proposed the concept of
'field cancerization' to explain the multicentric origin of
squamous cell carcinoma arising in a given anatomical
region, exposed to the same carcinogenic agents. The
diagnosis of a second primary tumour in the same anatom-
ical site, or the coexistence of premalignant lesions such
as leukoplakia or erythroplakia, suggests that the entire
mucosa is at risk of malignant change. Satisfactory treat-
ment for patients with such a wide field change should
ideally be non-mutilating and repeatable.
Photodynamic therapy (PDT), in which exogenous
photosensitizing drugs are administered to render tumour
tissue sensitive to nonthermal light, is beginning to be
recognized as an effective therapeutic modality (Pass,
1993). Early clinical experience shows that PDT is effec-
tive in the treatment of superficial lesions, particularly
such clinical entities as urothelial bladder cancers, early
bronchogenic carcinomas and dermatological tumours
(Hayata et al., 1984; Benson, 1988; Carruth, 1990; Edell
and Cortese, 1990; Pope and Bown, 1991a). A mixed
experience has been reported in the treatment of head and
neck cancers; reasons for initial failures include inappro-
priate patient selection, or failure to expose deep exten-
sions of the tumour to adequate light (Gluckman, 1991a).
The patient with a wide field change in the oral cavity
presents a difficult management problem. Screening of
these patients results in detection of areas of invasion
while still at an early stage. The ability of PDT to ablate
superficial tumours, while at the same time minimizing
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TABLE I
Patient Tumour site
Associated
premalignant disease
Primary cancer with associated premalignant disease
1
2
3
4
5
R bucco-gingival sulcus
R lateral tongue
L buccal mucosa
Tongue (excised)
L bucco-gingival sulcus
Multiple primary with associated ]
6
7
8
9
10
11
L buccal mucosa — 2 sites
R alveolar ridge
L alveolar ridge
Tongue tip
Palate/Lbuccal/R alveolus
Lip
R and L buccal mucosa
R tongue base, L buccal
mucosa
L buccal mucosa — 3 sites
L and R buccal mucosa
L buccal mucosa
premalignant disease
L buccal mucosa — 2 sites
R buccal mucosa, floor of
mouth
R buccal mucosa and alveolus
Dorsum and lateral tongue
R tongue and buccal mucosa
Lip
Appearance of treated
areas at 6-8 weeks
CR, Normal*
CR, Normal
CR, Non-healing ulcer
CR, Normal
CR, Persistence of
OSF
CR, Normal
CR, Normal*
CR, Normal
IR, Some leukoplakia
CR, Normal*
CR, Normal
Follow-up
10 months
8 months
9 months
3 months
19 months
9 months
10 months
7 months
18 months
6 months
18 months
Comments
HIV positive
Leukoplakia at 6 months: mild
dysplasia
Ulcer excised at 3 months:
inflammatory
Erythroplasia 1 year — moderate
dyplasia. OSF
Metachronous primary 8 months
Biopsied: moderate dysplasia
Metachronous primary 3 months
CR = Complete response: no evidence of abnormal mucosa, either histologically or clinically, at time of assessment; IR = incomplete response:
residual premalignant lesion in treated area; OSF = oral submucous fibrosis. * = Biopsied: histologically normal mucosa.
loss of normal tissue suggests that it should be ideally
suited to the treatment of this disease. This study reports
clinical experience with photodynamic therapy using
Photofrin (Lederle Laboratories) in the treatment of
superficial early carcinomas, with coexisting premalig-
nant lesions and areas of carcinoma in situ, occurring in
the oral cavity.
Materials and methods
Eleven patients with one or more histologically proven
early invasive squamous cell carcinomas of the oral cav-
ity, occurring in association with widespread pre-
malignant disease such as leukoplakia, erythroplakia or
'erythroleukoplakia', were included in the study group.
Six patients had synchronous or metachronous second
primary carcinomas, and five had a first primary lesion,
occurring in association with one or more non-contiguous
areas of leukoplakia of more than 5 mm in diameter (see
Table I).
All tumours were diagnosed as Stage I (T,N0M0) oral
cancers and no deep extension to underlying muscle or
bone was suggested by the clinical, histological or radio-
logical findings. Six patients had had previous oral
tumours surgically excised, five on more than one occa-
sion, and now presented with independent second primary
carcinomas. One patient had previous CO2 laser excision
of dysplastic areas of leukoplakia. Four patients had no
prior treatment but had histologically proven squamous
cell carcinomas associated with one or more non-con-
tiguous areas of leukoplakia. One patient underwent a
combination of surgical resection of a Tl lesion of the
tongue and PDT to extensive areas of leukoplakia in both
buccal regions. No patient had received radiotherapy.
Informed consent was obtained in each case.
Photofrin at a dose of 2 mg/kg was given by intra-
venous infusion 48 hours prior to surface illumination of
the tumour and all clinically apparent areas of leukoplakia
or erythroplakia. A copper vapour pumped dye laser was
used to deliver monochromatic red light at 630 nm. An
optical fibre with a microlens affixed ensured homo-
geneity of the illuminating light spot, and a multijointed
articulated arm was used to facilitate positioning of the
fibre in three planes. Two patients were treated for very
extensive disease on two separate occasions. Ten patients
required more than one spot to treat the target areas. A
light dose of 50-100 J/cm2 was delivered to each area.
Power densities were kept below 150 mW/cm2 to avoid
any possibility of thermal injury, and no patient reported
any sensation of heat, although some described various
sensations such as tingling and tickling during light expo-
sure. Patients were counselled to avoid direct sunlight for
six weeks following sensitization, and this advice was
reinforced by the provision of a patient advice sheet.
Patients were then prescribed analgesics and benzyda-
mine local analgesic/anti-inflammatory spray.
Lesions were photographed and treatment areas were
recorded diagrammatically on referral. Following treat-
ment patients were reviewed and photographed twice in
the week after PDT and then approximately weekly until
healed, and thereafter every two to four weeks. Where
treated areas healed with, or subsequently developed, evi-
dence of recurrence of ulceration, erythroplasia or leuko-
plakia, these lesions were conventionally excised or
biopsied to determine the nature of the abnormality and
the presence or otherwise of premalignant or malignant
recurrence. Three patients had biopsies of regenerated
clinically normal mucosa, at sites where invasive car-
cinoma had been previously diagnosed. Each was taken at
times longer than three months following PDT.
Initial response to treatment was evaluated at between
six and eight weeks. All cases were then followed-up for
periods of three to 19 months to determine whether any
early relapse occurred.
Results
All treatments were performed without local anaes-
thetic or sedation and were satisfactorily tolerated by each
patient, on an out-patient basis. During the three to four
days after PDT the treated areas underwent obvious sur-
face necrosis with the development of a superficial slough,
and local oedema. While no pain was associated with the
treatment itself, all patients developed some degree of
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FIG. 1
Photomicrographs of patient 10: before, (a) showing invasive
squamous cell carcinoma of the left hard palate and buccal mucosa;
and (b), 3 months after PDT showing appearance of palate following
healing.
pain over the following days, usually lasting about one
week, but this was effectively relieved by oral analgesia.
Eating tended to exacerbate pain and a sloppy diet was
advised and found to help. Treated areas took between
three and five weeks to heal fully, depending on the size of
area treated.
At assessment following healing six to eight weeks
after PDT, 10 of the 11 patients showed a complete
response to treatment. In eight the healed mucosa was of
normal colour with no evidence of leukoplakia or eryth-
roplakia (Figure la and b). Five patients who had had
multiple surgical resections (patients six to ten; Table I),
showed evidence of scarring related to previous surgical
intervention, but healed with essentially normal mucosa.
The three cases in which clinically normal regenerated
mucosa was biopsied after three months, showed histo-
logically normal epithelium in two cases (Figure 2a and
b), and an atrophic epithelium without atypia or dysplasia
in the third. One patient with pre-existing oral submucous
fibrosis healed with scarring, similar in appearance to
adjacent untreated mucosa. One patient had a persistent
non-healing ulcer associated with dental trauma. This was
excised after three months and showed simple ulceration
with chronic inflammation.
One patient had an incomplete response, but had almost
the entire surface of his tongue treated in two separate
treatments. More than 75 per cent healed with regener-
ation of mucosa of normal colour but with some atrophy,
and the persistence of a patchy grey-white lesion on the
dorsum, showing histological mild dysplasia, meant that
this constituted an incomplete response (Figure 3a and b).
Follow-up to date ranges from three to 19 months, with
a mean of 11 months. No patient has developed any evi-
dence of recurrence of invasive squamous cell carcinoma
in the treated sites. One patient developed a small area of
leukoplakia at the treatment site at six months. This was
excised and histology showed hyperkeratosis with moder-
ate epithelial dyplasia. The patient with oral submucous
fibrosis developed further erythroplakia at one year which
when excised also revealed moderate epithelial dysplasia.
Two patients developed further metachronous primary
carcinomas at sites away from the treated areas, while
maintaining a complete response in the treated area. These
were treated with excision and radiotherapy. The remain-
ing seven patients have had no evidence of recurrent car-
cinoma or further premalignant disease.
Discussion
The complete response of 10 of the 11 patients treated
in this study demonstrates the efficacy of PDT in ablation
of early invasive and premalignant lesions in the oral cav-
ity. The finding that in most cases the abnormal epithelium
healed with regeneration of essentially normal mucosa
indicates that early superficial carcinomas and associated
dysplastic lesions can be effectively destroyed in situ with
minimal tissue loss using PDT. The two cases that devel-
FIG. 2
Photomicrographs of histological sections showing: (a) early invas-
ive carcinoma of the right lower bucco-gingival sulcus before PDT;
and (b) showing appearance following healing with normal mucosa.
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FIG. 3
Photomicrographs of patient 9: before (a) and after (b) PDT for
extensive 'field cancerization' of the tongue. Patient had multiple
prior surgical resections of tongue and lower lip. Appearance at 16
months following PDT.
oped recurrent areas of dysplasia at six months and one
year respectively were disappointing but given the nature
of their field change not unexpected. Both patients sub-
sequently had these lesions excised, but further PDT
would certainly be a treatment option in the future. The
development of metachronous primary cancers in two
patients is also not unexpected and again reflects the field
change nature of the disease rather than any influence of
PDT, as the sites were not related.
The incidence of second or multiple cancers arising in
the upper aerodigestive tract has been variously reported
as being from seven to 30 per cent (de Vries, 1990). The
presence of more than one primary carcinoma has a pro-
found influence on survival, and therefore management.
Cohn and Peppard (1980) found that 75 per cent of
patients who developed second primary tumours in the
upper aerodigestive tract died within 12 months of the
second diagnosis. Gluckman and Crissman (1983) found
that overall five-year survival after diagnoisis of a second
primary was 22.3 per cent (compared with 35 per cent for
a control group with single lesions). Carr and Langdon
(1989) found that the average survival of patients with
index oral cancers who developed second primaries was
seven months. Two-thirds of this series died less than six
months after diagnosis of the second tumour. Close fol-
low-up screening of all patients with a diagnosis of upper
aerodigestive tract carcinoma is necessary to facilitate
early detection of a second primary and recurrent disease.
Similarly patients with leukoplakia showing histological
evidence of dysplasia, but without frank invasion, require
close follow-up. Both these situations present the oppor-
tunity for the histological diagnosis of carcinoma at a
stage when deep invasion has not yet taken place, and
when the lesion may be amenable to either further resec-
tion, or less mutilating interventional techniques, such as
PDT.
Management of areas of dysplastic oral mucosa is a
considerable problem because of multiple sites, often dif-
fuse margins and variable and unpredictable risk of malig-
nant transformation. Similarly management of an isolated
primary tumour by surgical resection with safe oncolog-
ical margins, and effective reconstruction where necess-
ary, may in itself also pose considerable difficulty. When
leukoplakia occurs in conjunction with one or more
primary tumours, indicating the likelihood of a wide field
change, these difficulties are greatly compounded.
Therapeutic options for patients with extensive 'field
cancerization' will depend on several factors, including
the timing of presentation of the tumours, whether simul-
taneous or metachronous, the site and stage of the lesions,
and the age and general health of individual patients. Con-
cern has frequently been expressed about the possibility of
radiotherapy converting premalignant disease into ana-
plastic and frankly invasive carcinoma, and the long-term
effect of radiation on the regional field mucosa remains
unclear. Normal oral mucosa exposed to ionizing radi-
ation during the treatment of orofacial tumours displays
abnormal DNA profiles, which although returning to
normal within six weeks, retains the potential for latent
radiation damage (Ogden etal., 1989). Children and ado-
lescents exposed to irradiation show a predisposition to
neoplasia in the head and neck (Martin etal., 1970; South-
wick, 1977; De Groot et al., 1983). Robinson et al., 1991
report decreased mean survival times for patients with
second primary head and neck cancers where index
tumours received radiotherapy over patients who had sur-
gery alone. For simultaneous primary cancers surgical
resection may be feasible if two or more primary lesions
are in close geographical proximity, but may offer the
prospect of extensive reconstruction with unacceptable
loss of function and cosmesis if occurring at different
sites. For metachronous lesions curative surgery is under-
taken on the merits of the individual case, but the prob-
lems of function and cosmesis are the same. Other
approaches to the management of premalignant lesions of
the oral cavity include the use of retinoids, but the
improvements in oral leukoplakia produced by treatment
with vitamin A related compounds have not all been sus-
tained and, more seriously, toxicity has been an accom-
paniment of some treatments (Scully and Boyle, 1992).
Photodynamic therapy has been shown to be effective
in vitro, and in vivo for the ablation of small areas of
malignant disease. Selective photodynamic destruction of
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tumour without injury to normal tissue has not been poss-
ible using currently available photosensitizing drugs.
However the ability of surrounding normal tissues to heal
satisfactorily by regeneration, coupled with the selective
illumination of target areas results in ultimate selectivity
of tumour destruction. Normal tissues in the oral cavity,
notably mucosa, muscle and salivary gland have been
shown, in studies in rats, to heal or regenerate well fol-
lowing PDT using a sulphonated phthalocyanine sensi-
tiser. Bone appeared to be resistant to photodynamic
injury (Meyer et al., 1991). Further studies in rats show
that PDT-treated stomach, colon and bladder healed
largely by regeneration with normal tissue (Barr et al.,
1987; Pope and Bown, 1991b; Loh et al., 1992). Clinical
studies demonstrate excellent healing of skin and mucosal
surfaces following PDT with Photofrin (Gilson et al.,
1988; Barr et al, 1990). Photodynamic therapy offers the
potential for minimal tissue loss with preservation of
function. The present study confirms these observations in
the oral cavity, and demonstrates that diffuse areas of
superficial malignancy and premalignant disease can heal
with clinically or histologically normal mucosa following
treatment.
Early clinical reports of PDT in the head and neck com-
prise feasibility studies in patients with advanced disease,
and demonstrate variable tumour response and palliation.
Visible light penetration is maximal in the red region of
the spectrum, but is not capable of causing necrosis of
more than a few millimetres from the surface so that sur-
face illumination of bulky tumours is likely to be of little
value. More recently it has been recognized that PDT is
more appropriate for the treatment of superficial lesions.
Wenig et al. (1990) used PDT to treat 26 patients with
early stage head and neck cancer who refused conven-
tional treatment or failed previous treatment of surgery,
radiotherapy, chemotherapy or combination therapy.
These authors used an 'idealized' mathematical light
dosimetry model to match light delivery to magnetic res-
onance imaging of tumour volume. Complete responses
were reported in 20 (77 per cent) and partial responses in
five (19 per cent) as assessed at three months. Nine of
these patients had oral cavity tumours. Unfortunately
there appears to be a wide variation in the optical proper-
ties of individual tumours and few conform to idealized
geometries (Grant et al., 1992). Gluckman (1991b)
treated 13 early (Tl and T2) carcinomas of the oral cavity
and oropharynx by surface irradiation. He obtained com-
plete response in 11 (84 per cent) at 1 month, with the
remaining two being partial responses. However, of these
11, four recurred between eight and 12 months. He con-
cedes that this high late recurrence rate may have been due
to a variety of factors and expresses concern about the
possibility of deep tumour being left untreated. The same
author, in the only other study to address 'field cancer-
ization' patients, reports results in eight patients with con-
demned mucosa (defined as biopsy proven multicentric
premalignant and overtly malignant lesions). He obtained
excellent results in seven patients in the short term. A
number developed recurrent leukoplakia on long-term fol-
low-up but only one was 'positive' on biopsy. Seven out of
eight patients with condemned mucosa had a complete
response at follow-up from six to 53 months. He found
that results achieved in aiming to palliate eight patients
with advanced cancer were disappointing and in fact skin
photosensitivity may have worsened their quality of life
and therefore he abandoned PDT for this indication.
These and other experiences with PDT both in the head
and neck and in other sites have contributed to the grow-
ing body of opinion that PDT should be confined to the
treatment of early superficial malignancies only.
The principle shortcomings of PDT using Photofrin are
essentially twofold: first the failure of light to penetrate
deeper than a few millimetres beneath the surface, or from
the light source in the case of interstitially implanted
fibres, and secondly the prolonged retention of photo-
sensitizing drugs by the skin resulting in protracted cuta-
neous photosensitization. In the management of a wide
field change disease, regular clinical examination offers
the opportunity for early diagnosis of malignant transfor-
mation. If representative histological sections confirm that
the lesion is confined to the mucosa, then successful
photodynamic ablation is likely. The second problem is
that of cutaneous photosensitization, with drugs such as
Photofrin, making protracted periods of avoidance of
direct sunlight a necessity. This problem is likely to be
eliminated with the next generation of photosensitizing
agents, such as aminolaevulinic acid (Grant et al., 1993),
which are more rapidly cleared from the skin. Further-
more improved selectivity may become possible with new
photosensitisers, and the conjugation of such drugs with
tumour specific monoclonal antibodies may further
improve this situation, although little progress has yet
been made in this direction.
This study demonstrates the efficacy of PDT in ablation
of early invasive and premalignant lesions in the oral cav-
ity. A viable therapeutic alternative to extensive mutilat-
ing surgery may thus be offered. While long-term
follow-up is necessary to determine recurrence of pre-
malignant and overtly malignant foci, and this is certainly
likely by the very nature of the disease, it must be empha-
sized that unlike conventional techniques such as surgery
or radiotherapy, PDT may be repeated without loss of
normal tissue. Irreversible side effects such as those seen
in salivary, bony and vascular tissues with radiotherapy
are also avoided. PDT offers the prospect of effective in
situ treatment of both early invasive malignancy and co-
existent premalignant disease. Where more advanced
malignancy occurs in a background of condemned
mucosa, PDT may be considered as an adjunct to local
resection, or debulking, of the primary focus.
Conclusion
Photodynamic therapy offers a welcome therapeutic
option in the treatment of multifocal 'field cancerization'
of the upper aerodigestive tract. Its use alone, or where
indicated, in conjunction with surgical excision, offers
functional and cosmetic advantages over conventional
treatment modalities for this difficult condition. While
long-term follow-up data is still required, repeated treat-
ment with PDT may offer a more acceptable option than
multiple surgical resections.
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